FDA Inspection 1018449 — James Benjamin Renfroe MD
The FDA completed an inspection of James Benjamin Renfroe MD on June 30, 2017 in Gulf Breeze, FL. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- June 30, 2017
- Fiscal Year
- 2017
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Gulf Breeze, FL (United States)
Additional Details
Clinical Investigator (CI)